US Health Landscape: Dengue Alerts, COVID-19 Vaccine Updates, and FDA Drug Approvals in the Last 30 Days

Health

A compilation of critical U.S. health news from the past month, covering infectious disease alerts, vaccine recommendations, and significant FDA actions.

Public Health FDA CDC Infectious Diseases Vaccines

10 Questions Hard Ages 16+ Jun 10, 2026

Practice Test PDF Answer Key PDF

Choose a Study Format

Quiz

Test your knowledge with multiple-choice questions and instant feedback.

Flashcards

Flip through cards to review terms, definitions and key concepts.

True or False

Quickly decide if statements are true or false to reinforce understanding.

Match Game

Race against time to match questions with their correct answers.

Study Guide

Read through all topics and answers as a comprehensive study reference.

Listen Mode

Listen to questions and answers read aloud — great for audio learners on the go.

Embed This Study Set

Add this interactive study set to your website or blog — all 6 formats included.

<div data-quixly-id="3453"></div>
<script src="https://www.quixlylearn.com/assets/embed/widget.js"></script>

Learn more about embedding →

About this Study Set

This study set covers Health through 10 practice questions. A compilation of critical U.S. health news from the past month, covering infectious disease alerts, vaccine recommendations, and significant FDA actions. Every question includes the correct answer so you can learn as you go — pick any format above to get started.

Questions & Answers

Browse all 10 questions from the US Health Landscape: Dengue Alerts, COVID-19 Vaccine Updates, and FDA Drug Approvals in the Last 30 Days study set below. Each question shows the correct answer — select a study format above to practice interactively.

1 In June 2024, the CDC issued a health alert regarding an increased risk of which mosquito-borne viral disease in the United States, noting record-breaking case numbers in the Americas?

A Zika Virus
B West Nile Virus
C Dengue Virus
D Chikungunya Virus

2 Which new COVID-19 vaccine variants are targeted by the updated Pfizer and Moderna vaccines recommended by the CDC for the fall/winter season?

A JN.1 and KP.3
B Omicron BA.5 and XBB.1.5
C KP.2 and KP.3
D JN.1 and Delta

3 The FDA granted traditional approval in June 2024 for Elevidys (sarepta therapeutics) for which condition in ambulatory patients aged 4 years and older?

A Cystic Fibrosis
B Duchenne Muscular Dystrophy (DMD)
C Sickle Cell Disease
D Huntington's Disease

4 As of June 24, 2024, how many dengue cases had been reported in countries in the Americas, more than double the number from all of 2023?

A Approximately 4.6 million
B More than 9.7 million
C Approximately 2.3 million
D More than 12 million

5 In June 2024, the FDA approved updated COVID-19 vaccines targeting specific variants. Which variant was targeted by the Novavax vaccine, while Pfizer and Moderna targeted others?

A KP.2
B JN.1
C Omicron BA.2
D XBB.1.16

6 The FDA approved durvalumab (Imfinzi) in June 2024 in combination with chemotherapy for which type of cancer, based on the DUO-E trial?

A Lung Cancer
B Breast Cancer
C Endometrial Cancer
D Colorectal Cancer

7 What is the new at-home diagnostic test authorized by the FDA in late 2024 that can detect both COVID-19 and Influenza A and B?

A A single nasal swab test from Healgen Scientific LLC
B A saliva-based multiplex PCR test
C A blood test from a major pharmaceutical company
D A breathalyzer device for respiratory viruses

8 The CDC issued a Health Alert Network (HAN) advisory on June 25, 2024, regarding an increased risk of dengue virus infections in the US. Which US territory has declared a public health emergency due to dengue cases?

A US Virgin Islands
B Guam
C American Samoa
D Puerto Rico

9 Which of the following oncology drugs received FDA approval in June 2024 for adult patients with primary advanced or recurrent endometrial carcinoma, based on the KEYNOTE-868/NRG-GY018 trial?

A Durvalumab (Imfinzi)
B Pembrolizumab (Keytruda)
C Ispelib (Vafseo)
D Avelumab (Bavencio)

10 The Congressional Budget Office (CBO) projected that US uninsurance rates would rise to 7.7% in 2024, an increase from 7.2% in 2023, partly due to the expiration of what pandemic-related policies?

A Telehealth flexibilities
B Enhanced ACA marketplace subsidies
C Pandemic Medicaid policies
D Hospital at Home waivers

📱

Study on the go

Download Quixly and access all study formats on your phone — anywhere, anytime.